Latest Content

A breast cancer survivor reflects on managing lymphedema, navigating Dupuytren’s disease and finding perspective when new health challenges arise.

Theresa Gannon’s compassion, leadership and dedication to patients and fellow oncology nurses make her an Extraordinary Healer Award nominee.

Dr. Maria Margarete Karsten discusses how weekly symptom monitoring helped identify changes between visits and what patients told her about using it.

Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.

Jim Day was told he had six months to live after a stage 4 melanoma diagnosis. A cancer-fighting virus helped shrink his tumors and gave him hope.

A UCLA study found patients with cancer who used biosimilars paid less out of pocket, and their insurers paid far less, than those on brand-name biologics.

Researchers are studying how genetics and environmental factors may influence lung cancer risk and could help shape the future of screening and treatment.

In the phase 2/3 STAR-TREC trial, 78.5% of patients given long-course chemoradiotherapy kept their rectum at 12 months, versus 60.6% with short-course radiotherapy.

In the phase 3 SHARE trial, salvage radiation given in 26 sessions kept cancer in check as well as 33 sessions did, with more late bowel side effects.

I have worked alongside Lori Ranallo for 23 years and watched her guide patients with breast cancer from diagnosis through survivorship and beyond.

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to recognize symptoms.

Nona Baker discusses the misdiagnoses that came first, why families need support and what has changed since.

A friend’s 28-year cancer journey taught one woman how to find hope, stay optimistic and live fully after her own incurable cancer diagnosis.